Last reviewed 2026-04-22 · How we verify

BaiDiZiYin Pill, ShenQiYiFei Pill

Beijing Chest Hospital · FDA-approved active Small molecule

BaiDiZiYin Pill, ShenQiYiFei Pill is a Small molecule drug developed by Beijing Chest Hospital. It is currently FDA-approved for Chronic respiratory weakness and qi deficiency, Pulmonary insufficiency and dyspnea.

These traditional Chinese medicine pills work to tonify qi, strengthen the spleen and lungs, and improve respiratory function through herbal synergy.

These traditional Chinese medicine pills work to tonify qi, strengthen the spleen and lungs, and improve respiratory function through herbal synergy. Used for Chronic respiratory weakness and qi deficiency, Pulmonary insufficiency and dyspnea.

At a glance

Generic name	BaiDiZiYin Pill, ShenQiYiFei Pill
Sponsor	Beijing Chest Hospital
Modality	Small molecule
Therapeutic area	Respiratory/Pulmonary Medicine
Phase	FDA-approved

Mechanism of action

BaiDiZiYin Pill and ShenQiYiFei Pill are herbal formulations designed to address deficiency patterns in traditional Chinese medicine, particularly targeting lung and spleen qi insufficiency. They combine multiple botanical ingredients to enhance respiratory capacity, reduce fatigue, and support immune function. These formulations are used in the context of respiratory and constitutional weakness.

Approved indications

Chronic respiratory weakness and qi deficiency
Pulmonary insufficiency and dyspnea

Common side effects

No common side effects on file.

Key clinical trials

Efficacy Safety BaiDiZiYin ShenQiYiFei Adjunctive Treatments Pulmonary Tuberculosis (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

BaiDiZiYin Pill, ShenQiYiFei Pill CI brief — competitive landscape report
BaiDiZiYin Pill, ShenQiYiFei Pill updates RSS · CI watch RSS
Beijing Chest Hospital portfolio CI

Frequently asked questions about BaiDiZiYin Pill, ShenQiYiFei Pill

What is BaiDiZiYin Pill, ShenQiYiFei Pill?

BaiDiZiYin Pill, ShenQiYiFei Pill is a Small molecule drug developed by Beijing Chest Hospital, indicated for Chronic respiratory weakness and qi deficiency, Pulmonary insufficiency and dyspnea.

How does BaiDiZiYin Pill, ShenQiYiFei Pill work?

These traditional Chinese medicine pills work to tonify qi, strengthen the spleen and lungs, and improve respiratory function through herbal synergy.

What is BaiDiZiYin Pill, ShenQiYiFei Pill used for?

BaiDiZiYin Pill, ShenQiYiFei Pill is indicated for Chronic respiratory weakness and qi deficiency, Pulmonary insufficiency and dyspnea.

Who makes BaiDiZiYin Pill, ShenQiYiFei Pill?

BaiDiZiYin Pill, ShenQiYiFei Pill is developed and marketed by Beijing Chest Hospital (see full Beijing Chest Hospital pipeline at /company/beijing-chest-hospital).

What development phase is BaiDiZiYin Pill, ShenQiYiFei Pill in?

BaiDiZiYin Pill, ShenQiYiFei Pill is FDA-approved (marketed).

Manufacturer: Beijing Chest Hospital — full pipeline
Therapeutic area: All drugs in Respiratory/Pulmonary Medicine
Indication: Drugs for Chronic respiratory weakness and qi deficiency
Indication: Drugs for Pulmonary insufficiency and dyspnea
Compare: BaiDiZiYin Pill, ShenQiYiFei Pill vs similar drugs
Pricing: BaiDiZiYin Pill, ShenQiYiFei Pill cost, discount & access